MTX Hold During Covid-19 Booster
NCT05313061 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2022-04-06
Summary
To investigate the effect of MTX discontinuation for 1 week on vaccination response to Covid-19 booster vaccination in RA patients.
Conditions
Interventions
- DRUG
-
MTX
MTX continuation
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-29
- Primary Completion
- 2022-12-30
- Completion
- 2022-12-30
Countries
- South Korea
Study Locations
More Related Trials
-
An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy
NCT03155347 ·Status: COMPLETED ·Phase: PHASE3
-
Methotrexate in Patients with Early Rheumatoid Arthritis
NCT05353829 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
NCT00409838 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate
NCT00282308 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis
NCT00299104 ·Status: COMPLETED ·Phase: PHASE3
-
Subcuteous Methotrexate in Rheumatoid Arthritis
NCT07094880 ·Status: COMPLETED ·Phase: PHASE4
-
Methotrexate Adherence in Rheumatoid Arthritis Patients
NCT05535686 ·Status: COMPLETED
-
A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis
NCT00299130 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
NCT00106548 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX)
NCT00928512 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate
NCT00243412 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis Patients
NCT01258712 ·Status: COMPLETED ·Phase: PHASE3
-
Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Methotrexate
NCT00235859 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008)
NCT01569152 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis
NCT00443651 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid Arthritis
NCT00896168 ·Status: COMPLETED ·Phase: PHASE4
-
COVID-19 Vaccination in Rheumatic Disease Patients
NCT04839315 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
TBE-vaccine to Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive Drugs
NCT01131910 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe
NCT02553018 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis (RA)
NCT00106535 ·Status: COMPLETED ·Phase: PHASE3
-
Leflunomide + Methotrexate in Rheumatoid Arthritis
NCT00563849 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)
NCT01163747 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
NCT01951170 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage
NCT01661140 ·Status: TERMINATED ·Phase: PHASE4
-
Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients
NCT00686868 ·Status: COMPLETED ·Phase: PHASE1